Discover 1,743 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,743
Study of BHV-1400 in IgA Nephropathy
for
IgA Nephropathy
Location: Shelby MI, Indianapolis IN, Hinsdale IL,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 65
Code: NCT07054684
Phase1, Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE),
Location: Troy MI, Flint MI, Indianapolis IN, Fairport NY,
Sponsor: Ventus Therapeutics U.S., Inc.
Sex: All
Age: 18 - 70+
Code: NCT07260877
Phase2, Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Detroit MI, Cleveland OH, Toronto, St Louis MO,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase1, Phase2, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Detroit MI, Toledo OH, Findlay OH, Columbus OH,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Detroit MI, Windsor, Toledo OH, Cleveland OH, Hamilton,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Detroit MI, Hilliard OH, Chicago IL, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT06787612
Phase2, Recruiting
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
for
Advanced Solid Tumors, Hematologic Malignancies
Location: Detroit MI, Canton OH, Chicago IL
Sponsor: Acrotech Biopharma Inc.
Sex: All
Age: 18+
Code: NCT07036133
Phase1, Recruiting
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Detroit MI, Chicago IL, Bethesda MD, Washington DC,
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Detroit MI, Lorain OH, Mayfield Heights OH, London,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 12 - 17
Code: NCT06979453
Phase3, Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion,